7 - Hemodynamics (2nd Half) Flashcards
Abnormal Blood Flow (Virchow): Turbulence contributes
To arterial and cardiac thrombosis by causing endothelial or dysfunction
Abnormal Blood Flow (Virchow): Turbulence and stasis contribute to thrombosis in several clinical settings (6)
Ulcerated atherosclerotic plaques
Aneurysms
Acute MI
Acute myocardial infarctions
Rheumatic mitral valve stenosis
Hyperviscosity
Sickle cell anemia
Hypercoagulability (Virchow)
AKA Thrombophilia
Is any alteration of the coagulation pathways that predisposes to thrombosis
Hypercoagulability (Virchow) is divided into
Primary (genetic)
Secondary (acquired) disorders
Hypercoagulability: Primary (Genetic) - Common (3)
*Mutation in Factor V (Leiden)
Mutation in prothrombin gene
Mutation in methyltetrahydrofolate gene
Hypercoagulability: Primary (Genetic) - Rare (3)
Anti-thrombin III Deficiency
Protein C Deficiency
Protein S Deficiency
Hypercoagulability: Primary (Genetic) - Very Rare
Fibrinolytic defects
Hypercoagulability: Secondary (Acquired) - High Risk for Thrombosis
- Prolonged bed rest or immobilization
- MI
- AFib (a SA node)
- Tissue damage (surgery, fracture, burns)
- Cancer (Pancreas)
- Prosthetic cardiac valves
- DIC
Hypercoagulability: Secondary (Acquired) - Low Risk for Thombosis
- Hyper estrogenic states (pregnancy)
- OCPs
Mnemonic to remember thrombophilia
THROMBI
T - Tissue Damage H - Hereditary (V leiden) R - Rest (prolonged) O - Obstetrics (eclampsia, abruptio) M - Malignancy B - Blood flow disturbances (MI, aneurysms, varicose veins) I - Immune mechanisms
Factor V (Leiden) Mutation is called the
G1691A mutation
Factor V (Leiden)/G1691A Mutation
Results in glutamine to arginine substitution at position 506 that renders factor V resistant to cleavage by Protein C
Important anti-thrombotic counter-regulatory pathway is lost
Recurrent DVT
Prothrombin gene mutation
Single nucleotide change (G20210A)
Elevated prothrombin levels
Threefold increased risk of venous thrombosis
Protein C
Anti-thrombotic factor made by liver
Vit. K Dependent
Binds to activated Facts 5 and 8
If patient has a clot in leg before age 50, suspect?
Genetic abnormality rather than environmental
Heparin-Induced thrombocytopenia (HIT) Syndrome
IOccurs following administration of unfractionated heparin
Antibodies to heparin +Platelet factor (pf)-4 complex and Pf-44 like proteins on the endothelial cells
Binding of antibodies results in activation, aggregation, and consumption (thrombocytopenia)
Low molecular weight heparin has less frequency
If you give unfractionated heparin, some part of heparin protein will also resemble proteins in the bod, so what ocurrs?
Cross reaction
Antiphospholipid Antibody Syndrome (APLA)
Previously called lupus anticoaglant syndrome
Name derived from binding of antibodies to epitopes on plasma proteins (e.g. prothrombin) that are induced or ‘unveiled’ by phospholipids
Antiphospholipid Antibody Syndrome (APLA):
The autoantibodies INDUCE a hypercoagulable state by? 3
Causing endothelial injury
Activating platelets and complement directly
Interactions with the catalytic domains of certain coagulation factors
Antibodies to beta-2 glycoprotein are expressed on?
Endothelial cells
Antibodies against anion phosphoplipids
Cardiolipin
What type of reaction is there for VDRL?
False positive
What happens in vitro? (I think it’s referring to VDRL)
Inhibits coagulation
What happens in vivo? (I think it’s referring to VDRL)
Hypercoagulable state
Clinical Features of APLA (10)
- Pulmonary embolism (following lower extremity venous thrombosis)
- Pulmonary hypertension (from recurrent subclinical pulmonary emboli)
- Stroke
- Bowel infarction
- Renovascular hypertension
- Renal microangiopathy
- Recurrent thrombosis
- Repeated miscarriages (due to ab-mediated inhibition of t-PA activity necessary for trophoblastic invasion of the uterus)
- Cardiac valve vegetations
- Thrombocytopenia
Morphology of Thrombus 3
- Develop anywhere in the cardiovascular system
2. Size and shape of thrombi depend on the site of origin and the cause
Sizes and shapes of thrombi depending on the site of origin and the cause
Venous thombi: at sites of stasis; extend IN DIRECTION of blood flow
Arterial thrombi: grow retrograde from the point of attachment
Lines of Zahn
Represent pale platelet and fibrin deposits alternating with darker red cell-rich layers
Are laminations seen in thrombi
*Signigy that a thrombus has formed in flowing blood
Distinguish ante mortem thrombosis from the bland non-laminated clots that occur postmortem
Thrombi occurring in heart are known as mural thrombi
Ante mortem Clot Characteristics (4)
- Adhere to vessel
- Have lines of Zahn
- Can’t be washed away
- Buffed in color
Postmortem Clot Characteristics (4)
- Do not adhere to vessel
- Absent Lines of Zahn
- Easily washed away
- Chicken fat appearance
Mural thombus
Occur in heart chambers or in the aortic lumen
- abnormal myocardial contraction
- Endomyocardial injury
- **Precursors of aortic thrombi
- ulcerated atherosclerotic plaque
- aneurysmal dilation
Cardiac Vegetations
- Thrombi on heart valves
- Infective endocarditis
- Nonbacterial thrombotic endocarditis
- *Libman-Sack’s endocarditis
Fate of Thrombus: 1st - Propagation
Thrombi accumulate additional platelets and fibrin
Fate of Thrombus: 2nd - Embolization
Thrombi dislodge and travel to other sites in the vasculature
Fate of Thrombus: 3rd - Dissolution
Result of fibrinolysis, which can lead to the rapid shrinkage and total disappearance of recent thrombi
Fate of Thrombus: 4th - Organization and recanalization
Older thrombi become organized by the ingrowth of endothelial cells, smooth muscle cells, and fibroblasts
Venous Thrombosis (Phlebothrombosis): Superficial Venous Thrombi
Saphenous veins affected in the setting of varicosities
Local congestion, pain, and if edema superadded, impaired blood supply –> ulcer
Venous Thrombosis (Phlebothrombosis): Deep Vein Thrombosis (DVT)
Larger leg veins: at or above the knee (e.g. popliteal, femoral, and iliac veins) - is more serious
More often embolize to the lungs and give rise to pulmonary infarction
C/F - local pain and edema